Clinical Trial Update: Effect of Food and Age on the Pharmacokinetics of LY03017 [Phase 1]

View source ↗

Summary

This update describes a Phase 1 pharmacokinetic study of LY03017 evaluating the effects of food and age on its pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease
• Schizophrenia

Drugs mentioned

• LY03017

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Alzheimer's Disease Psychosis, Parkinson Disease Psychosis | Phase 1 | Status: NOT_YET_RECRUITING